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Abstract
Background Detection, monitoring and treatment of
adverse drug reactions (ADRs) are paramount to patient
safety. The use of a comprehensive electronic health record
(EHR) system has the potential to address inadequacies in
ADR documentation and to facilitate ADR reporting to
health agencies. However, effective methods to maintain
the quality of documented ADRs within an EHR have not
been well studied.
Objective To evaluate the accuracy and effectiveness of
ADR documentation transfer throughout the implementa-
tion of a comprehensive EHR system.
Methods Retrospective analysis of ADR documentation at
a tertiary care pediatric hospital between January 2013 and
June 2014. ADRs documented in the newly implemented
ambulatory EHR, pharmacy system and hybrid health
record system were extracted. Documentation inconsis-
tencies and processes for managing ADR documentation
within the EHR were reviewed.
Results A total of 115 patients with 260 unique ADRs
were identified. Only 155 (60 %) of the identified ADRs
were found in the ambulatory EHR system. The remaining
105 ADRs (40 %) were missing from the EHR when it was
compared with the other systems. Seventy-two patients
(63 %) returned for a follow-up visit, and each had their
ADR documentation reviewed in the ambulatory EHR.
Following the visit, 44 % of these ambulatory EHR records
still included incorrect information.
Conclusions We identified discrepancies in ADR docu-
mentation within hospital systems, which need to be
addressed as healthcare institutions transition to EHRs.
Processes related to the transfer of ADR information into
the EHR should be clearly defined. To improve the quality
of ADR documentation, steps to force complete and con-
tinual ADR verification should be introduced at early
stages of implementation of a new EHR, and all respon-
sible providers should play a role.
Key Points
Comprehensive electronic health records (EHRs)
provide a modern solution in complementing and
improving the inefficiencies that exist with current
adverse drug reaction (ADR) documentation
methods in hospitals.
The process for transferring ADR information
between traditional paper-based and hybrid
documentation systems into our new ambulatory
EHR was scattered, laborious and inaccurate.
A successful EHR system must have the capacity to
both accurately document ADRs and ensure that
quality is maintained; hence, steps to ensure ongoing
ADR verification using an EHR system should be
implemented consistently, and all responsible
providers need to be vigilant.
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1 Introduction
Adverse drug reactions (ADRs), defined as an appreciably
harmful or unpleasant reaction resulting from an inter-
vention related to use of a medicinal product, are common
in children, accounting for up to 8 % of emergency
department visits and 2.9 % of hospital admissions [1–3].
Information on the general population regarding ADRs is
readily available, but monitoring and reporting of these
effects in children are still lagging. Children differ from
adults in terms of their risks of particular ADRs, yet many
of these events are equally preventable, hence detection,
monitoring and treatment of ADRs are paramount to
patient safety [2, 3]. Although it is common practice for
providers to document ADRs, effective methods to main-
tain the quality of ADR documentation are not well
established [4].
The use of an electronic health record (EHR) to detect,
monitor and document ADRs has emerged as a promising
complement to traditional documentation systems [5]. An
EHR is a digital version of a patient’s paper chart, which
contains real-time, patient-centered records. It gives
healthcare providers (HCPs) the ability to document and
access patient information in a prompt and secure manner.
This can be especially important in making timely clinical
decisions related to ADRs. Although most hospitals
already have processes in place to document ADRs, they
are still heavily reliant on paper charts or some form of
hybrid health record (HHR) system—a combination of a
paper chart and an EHR. Not only do paper-based sys-
tems have a higher risk of documentation errors, but also
new regulations will soon require all Canadian healthcare
institutions to have improved processes for documenting
and reporting ADRs [6]. Under the new Protecting
Canadians from Unsafe Drugs Act (Vanessa’s Law),
healthcare institutions in Canada will soon be required to
report all serious ADRs [7]. This legislation strengthens
the need for an effective ADR documentation and
reporting solution. Uncovering the root causes related to
ADR documentation discrepancies within a hospital sets
the stage for identifying the steps to improve ADR
reporting and quality. Ultimately, this will translate into
better quality and patient safety by providing accurate and
accessible ADR information needed to make the best
clinical decisions.
As part of the initial phase of a hospital-wide, compre-
hensive EHR platform, the newly implemented ambulatory
EHR system at our institution was designed for all clinical
information documentation and retrieval, including docu-
mentation of ADRs and prescriber order entries. The next
phase of implementation will add inpatient documentation,
medication dispensing records and documentation of
medication administration to the patient. Once complete,
the EHR will be the primary patient record.
Prior to the introduction of the EHR, recording and
reporting of ADRs was primarily performed in an HHR
system, which included paper charts combined with an
inpatient EHR containing only nursing and allied health
documentation. Upon implementation of the ambulatory
EHR, the plan for the import of ADR data and transfer into
the new system involved data abstraction from the HHR
system, followed by validation by a responsible HCP with
the patient/family. While chart abstraction is a common
procedure that hospitals use for transfer of information into
an EHR, abstraction accuracy and quality need to be
carefully monitored [8].
In the interim phase, at each outpatient visit, a clinician
will review and document any ADR information in the
EHR. At each inpatient visit, a clinician will initially
review and document any ADR information in the inpatient
EHR, which will then be confirmed by pharmacy staff
during a medication reconciliation process with the patient
and with the EHR, and any discrepancies will be updated.
In principle, the combined methods should provide high-
quality data, as the initial abstraction retrieves relevant
ADR information, while the clinical review corrects
inconsistencies.
As more hospitals transition to an integrated EHR
solution for documenting all medical information, it is
important that we regularly evaluate the process to ensure
the accuracy and quality of ADR documentation. The
purpose of this study was to evaluate the accuracy of ADR
information transfer and the effectiveness of the newly
implemented EHR system for ADR documentation upkeep.
2 Methods
2.1 Hospital and ADR Documentation Systems
This study was performed at a tertiary care pediatric hos-
pital in Canada providing level 1 trauma and level 3
neonatal care services, with 6000 admissions and 200,000
outpatient visits each year. The referral base is approxi-
mately 2 million people within 5000 square kilometers in
the immediate area and another 29,000 people within
2 million square kilometers remotely. In the ambulatory
setting, there are 79 clinics and 40 services. The imple-
mentation of the EHR is occurring over several phases,
starting with ambulatory clinics in October 2013 and
completion in 2018.
The accuracy and consistency of ADR documentation
between the hospital’s primary documentation systems
were evaluated by comparing the number and type of
ADRs found within each system. ADR documentation for a
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select cohort of patients was retrieved from three individual
health record documentation systems: (1) the HHR system,
which included paper charts combined with an inpatient
EHR containing only nursing and allied health documen-
tation (Sunrise Clinical Manager Version 5.0; AllScripts
Healthcare Solutions, Inc., Chicago, IL, USA); (2) the
pharmacy system (Centricity Pharmacy Version 9.0;
GE Healthcare, Little Chalfont, UK); and (3) the ambula-
tory EHR system (EpicCare Ambulatory 2012; Epic Sys-
tems Inc., Verona, WI, USA). The ADRs found in the
newly implemented ambulatory EHR system were then
compared with the documentation from the other two
systems. ADR inconsistencies were identified, and the
processes for managing ADR documentation within the
EHR were reviewed. This included reviewing the process
related to transfer of ADR documentation from the HHR
into the ambulatory EHR system and the process of ADR
documentation quality verification by HCPs.
2.2 Population Selection and Inclusion Criteria
Patients with ADR documentation were identified as fol-
lows. A list of patients who had their past medical infor-
mation abstracted into the ambulatory EHR system from
January 2013 to June 2014 was obtained. During the
ambulatory EHR implementation, patients had their infor-
mation abstracted from the HHR and entered into the EHR.
Abstraction was defined as retrieval and transfer of medical
information (including information on ADRs) by trained
health records personnel from the HHR system into the
new EHR system. Every instance of an abstraction was
documented as an abstraction encounter within the
patient’s EHR. Because the ambulatory EHR system had
been started only in October 2013, at the onset of this study
in June 2014 the number of records with completed med-
ical abstractions was relatively small in comparison with
the number of outpatient visits.
In an attempt to exclude patients with no documented
ADRs, this list was further refined to include only patients
previously admitted to the hospital with ADRs documented
in the pharmacy system. The study relied on the accuracy
of ADR documentation in the pharmacy system to identify
patients. This provided a final cohort of patients consisting
of known documented ADRs, allowing for effective pro-
cess evaluation of ADR documentation transfer into the
EHR.
2.3 Collection and Comparison of ADR
Documentation
ADR information listed in the pharmacy and EHR systems
was extracted electronically, while ADR information in the
HHR system was retrieved through manual data collection
by a pharmacy research assistant from June 2014 to
September 2014. An ADR was recorded if there was
documentation suggesting a link between a suspected drug
and a reaction. Details surrounding the time and duration of
an ADR were recorded, and the ADR category was clas-
sified using the National Cancer Institute’s Common Ter-
minology Criteria for Adverse Events (CTCAE) modified
to specifically capture ADR details. The severity and grade
of an ADR was recorded using the Merck Manual Classi-
fication of Adverse Drug Reactions [9, 10]. The location of
the ADR documentation within the HHR system was also
recorded.
Data were collected into a Research Electronic Data
Capture (REDCap; Vanderbilt University, Nashville, TN,
USA) database and analyzed in REDCap and Microsoft
Excel (Microsoft Inc.) [11]. ADRs that were identified in
the HHR or the pharmacy system but not in the EHR were
identified. Descriptive statistics were performed by a senior
pharmacy research assistant and hospital pharmacists. The
frequency, counts and distribution of ADRs between the
different documentation systems were compiled and com-
pared (see Supplementary Fig. 1 in the Electronic Sup-
plementary Material).
2.4 Quality Assurance
As the hospital’s standard of practice, all responsible HCPs
had been instructed to verify ADRs abstracted in the EHR
during subsequent patient visits. The completeness, quality
and accuracy of this verification process were reviewed.
ADR documentation in the EHR was considered accurate
and consistent if it matched the documentation in the HHR
and pharmacy systems. As soon as they were identified,
immediate resolutions were taken to contact the HCPs and
rectify unverified or discrepant ADRs that had the potential
risk to cause serious patient harm or jeopardize the provi-
sion of care.
3 Results
At the time of the investigation, there was a list of 1562
patients for whom medical abstractions in the EHR were
completed. After cross-referencing of this list with the
pharmacy system to identify records with previously doc-
umented ADRs, 115 patients (7 %) fitted the inclusion
criteria for the study.
3.1 ADR Documentation Quality
Patient records were reviewed for ADRs in each of the
three ADR documentation systems. A total of 260 unique
ADRs were identified; however, only 186 contained
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descriptive details allowing for grading of severity. Of
these, 116 were graded as a moderate-severity reaction,
while 12 were graded as severe or life threatening
(Table 1).
Similarly, ADRs were classified according to the
descriptive details surrounding a reaction; however, only
101 ADRs had sufficient information suitable for classifi-
cation into categories (Table 2). The remaining ADRs were
linked to a suspected drug but could not be classified on the
basis of the documentation provided (e.g., a drug reaction
to sulfa). Antibiotic-derivative ADRs were the most well
documented therapeutic category, but details related to the
type of reaction were often absent (see Supplementary
Table 1).
3.2 ADR Documentation Process in the EHR
Of the 260 identified ADRs, only 155 (60 %) were found in
the ambulatory EHR system. The remaining 105 ADRs
(40 %) were missing from the ambulatory EHR when it
was compared with the HHR and pharmacy systems
(Table 3). A review of the ADR abstraction process
revealed that ADR information was abstracted directly
from an ADR medication sheet found in the paper charts of
the HHR system. The sheet was absent in 27 records
(23.5 %), and many ADRs were identified only from other
locations within the HHR system (Fig. 1).
To maintain the quality and accuracy of ADR informa-
tion, the ambulatory EHR was integrated with a function to
review previously reported ADRs within the system itself.
HCPs were prompted to verify ADRs with the patient or
family during every visit and were encouraged to correct
inconsistencies when appropriate. At the time of the analy-
ses, 15 months post-EHR implementation, 72 (63 %) of the
115 patients in the cohort had returned for a follow-up visit
and would have consequently had their ADR documentation
reviewed in the ambulatory EHR. The reviews in the
ambulatory EHR were performed primarily by nurses
(47 %) and physicians (14 %), and infrequently by phar-
macists (1 %) and social workers (1 %) (Fig. 2). The
reviews resulted in updated or more accurate ADR docu-
mentation in 56 % of the records, yet the remaining 44 % of
the ambulatory EHR records still had incorrect ADR infor-
mation when these data was compared with those in the
other two documentation systems. Nurses were involved in
these incomplete ADR reviews 83.3 % of the time, followed
by physicians (12.5 %) and social workers (4.2 %).
Table 1 Severity of documented adverse drug reactions (ADRs)




4: life threatening 1
ADRs were graded according to the descriptive documentation
available (n = 186)























Musculoskeletal and connective tissue disorders: other 1
Nausea 1
Nervous system disorders: other 1
Pruritus 3
Psychiatric disorders: other 2
Renal and urinary disorders: other 2
Reproductive system and breast disorders: other 1
Respiratory failure 1
Respiratory, thoracic and mediastinal disorders: other 1
Seizure 1









159 of the 260 ADRs did not have sufficient information for an
accurate classification (n = 101)
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4 Discussion
In most hospitals, methods to document ADRs include the
use of traditional medical charts, HHR systems, and indi-
vidual department-specific documentation systems, such as
those used in the pharmacy or the emergency department.
The system of choice depends on many factors, including
the location of the ADR discovery and the time of ADR
reporting, as well as the profession of the HCP involved.
ADRs are often documented only in the system that is
convenient and familiar to the HCP. Because of lack of
integration between many traditional documentation sys-
tems, ADR information may be inaccessible to providers
utilizing other documentation systems within the hospital.
This results in inadequate, duplicated and missing ADR
information, which can jeopardize the quality of care and
patient safety.
Comprehensive EHRs provide a modern solution in
complementing and improving the inefficiencies that exist
with current ADR documentation methods. With correct
oversight, EHRs can help institutions to better address
limitations in ADR documentation and help to regulate
ADR reporting to governing agencies. However, a suc-
cessful EHR system must have both the capacity to accu-
rately document ADRs and the processes needed to ensure
that the quality of ADR documentation is maintained.
The integrated ambulatory EHR system was expected to
decrease repetition and correct inconsistencies in ADR
documentation. While this is expected to improve over
time, the current processes were not effective in ensuring
the quality of ADR information entered into the new EHR.
A significant number of ADRs documented within both the
pharmacy and HHR systems were absent in the ambulatory
EHR. Considering the severity of many of the ADRs, these
missing documentations can have significant impacts on
patient safety, which emphasizes the need for processes to
improve the quality of ADR documentation.
One factor that might have contributed to this discrep-
ancy is that the ambulatory EHR is the first clinical system
of an enterprise-wide, comprehensive EHR—which will
include all ambulatory, acute care (inpatient care, operating
rooms and the emergency department) and pharmacy
Fig. 1 Locations of adverse
drug reaction (ADR)
documentation identified within
the hybrid health record (HHR)
system; 235 ADRs were
documented in the HHR, and
many ADRs were documented
in more than one location within
the system (n = 115 patient
records)
Table 3 Adverse drug reactions (ADRs) identified within the hospital’s three primary documentation systems
Total number of ADRs identified
throughout all systems
Number of ADRs
identified in the EHR
Number of ADRs missing
from the EHR
Distribution of missing ADRs
260 155 105 64 ADRs documented in the HHR system but not
in the EHR
12 ADRs documented in the pharmacy system
but not in the EHR
29 ADRs documented in the HHR and pharmacy
systems but not in the EHR
n = 115 patient records
EHR electronic health record, HHR hybrid health record
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systems—to be implemented. Even so, 15 months into the
implementation of the EHR, only 60 % of the known
extracted ADRs were captured in the system. This per-
centage was much lower than expected and was likely due
to the fact that ADR information was pulled exclusively
from a single ADR medication sheet instead of being
abstracted from the entire chart or other systems. Prior to
the implementation of the ambulatory EHR, the ADR
medication sheet was the standard source for documenting
and updating all ADRs. Although it was designed for this
purpose, the functionality and reliability of the sheet was
questionable. Not only was the ADR medication sheet
often unavailable, but also no standards were in place for
auditing this process. A significant number of ADRs found
within the discharge summaries, physician letters and other
sections of the charts were never listed on the ADR med-
ication sheets, which led to incomplete ADR abstraction.
In this instance, the resources allocated to abstraction
(retrieval from a defined section of the HHR) proved to be
insufficient for retrieving ADR documentation. It is
expected that complete abstraction of ADR information
from all sections of the HHR system would have provided
better results; however, this process is long, laborious and
expensive. A better strategy would be to perform a pre-
scope into the charts to identify specific sections of the
HHR system that contained a high prevalence of ADRs.
Expanding the ADR abstraction procedure to these other
areas within the HHR system would likely have increased
the quality of abstraction without significantly increasing
the duration of the process. Furthermore, abstraction from
other department-specific documentation systems, such as
those used in the emergency department and pharmacy,
would allow more opportunities to identify concise ADR
information. The challenge remains in finding an optimal
balance of time and resources for facilitating this process
within an institution.
Although other healthcare institutions may have differ-
ent systems for documenting ADRs, our results suggest
that standardization for ADR validation and monitoring is
currently lacking. As was demonstrated in this study, ADR
documentation may be distributed in different locations
throughout the hospital, making it difficult to retrieve
accurate information in a timely manner. Devising struc-
tured means to make it easy and convenient to regularly
review and validate ADRs, regardless of the system, may
aid in improving the quality of ADR documentation [12].
To address the common problems of abstraction quality,
the hospital applied a patient-centric strategy in an attempt
to correct ADR documentation inconsistencies incurred in
the abstraction process [13, 14]. This strategy involved
using HCPs to provide continual oversight of ADR docu-
mentation quality by encouraging them to verify ADR
documentation in the ambulatory EHR during clinic visits
or hospital admissions. At the time of the analyses, 37 % of
the patient cohort had not returned for a follow-up visit and
did not have their ADRs reviewed. Nonetheless, for the
patients who had their ADRs reviewed, a third of the EHRs
had discrepant ADR documentation that was uncorrected
or inaccurate. A possible explanation for the uncorrected
documentation following a patient visit may be shortcom-
ings in communication between the provider and patients.
Concentrating on the primary purpose for the clinic visit,
HCPs may not have taken the time to ask direct questions
to fully verify the ADR documentation; likewise, patients
and parents may not have the knowledge to communicate
the details of a past ADR. Furthermore, there may be a
difference between HCPs’ and patients’ understanding of
the definition of an ADR. Typically, the question that is
asked is whether or not a patient has ‘‘allergies’’ to medi-
cations, which may not elicit recall of ADRs. Similarly,
HCPs in specialty clinics may not update information on
ADRs to drugs used outside their specialty, because of lack
of knowledge.
Because the patient–provider interaction is typically
spent with nurses or physicians, pharmacists were involved
in only 1 % of the ADR reviews. This low value was also
likely a result of pharmacists updating ADR information (if
ADRs were identified in the inpatient setting) within the
pharmacy’s independent system and not in the new
ambulatory EHR. Because our methodology measured
ADR reviews only in outpatient encounters, ADR reviews
Fig. 2 Review of adverse drug reaction documentation in the
electronic health record (EHR) system by healthcare providers during
follow-up patient visits to the hospital. The reviews were performed
over a period of 15 months post-implementation of the EHR system
(n = 72 patient records)
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performed by pharmacists for inpatients would not have
been captured. Until synchronization of the pharmacy
system and the EHR occurs, pharmacy staff have been
encouraged to document ADRs in both systems, but the
compliance is poor. In the interim phase, a new ADR that is
identified in the inpatient setting would be documented in
the patient’s EHR record only upon review at a subsequent
outpatient visit. Once the EHR is fully implemented, all
ADRs will be documented in the EHR and will be viewable
by all, regardless of the type of visit. Allowing opportu-
nities for pharmacists to provide input during ADR
reporting at clinic visits would likely increase the accuracy
of the ADR information [15, 16]. Maintaining accurate
ADR documentation is the responsibility of all HCPs, and
it is important that they work collaboratively to achieve
this goal.
Oversight of the quality of ADR documentation has
been lacking because of low awareness in maintaining
ADR quality and the complacency of HCPs in accepting
minimal standards for ADR reporting [17]. As new stan-
dards and legislation related to ADR reporting are expec-
ted, strategies to improve the quality and consistency of
ADR documentation are necessary. While the EHR system
at our hospital is still being implemented, it is most
important to evaluate the effectiveness of ADR documen-
tation and apply approaches to improve function. As with
many technologies, successful implementation requires an
appropriate amount of resources, time and commitment,
and attention to the people, process and technology. End
users must take the initiative to familiarize themselves with
the important functions in a new EHR system and be
engaged in providing process improvement feedback.
Increasing awareness of ADRs throughout the hospital
must then be followed by actions to simplify and encourage
the process for accurate ADR review. For example, forcing
functions can be used in the EHR to prevent HCPs from
completing a request for patient discharge or billing unless
they have first verified the listed ADRs. Fields within the
reporting structure can also be restricted to a set of cate-
gorical choices so that consistency of the data can be
maintained. Taking it one step further, algorithms can be
developed to interpret signals or laboratory values that alert
a HCP about the need to document an ADR or update
existing ADR documentation [18, 19]. As more hospitals
begin to transition to a comprehensive EHR system,
effective methods for the transfer of ADR documentation
and continual oversight of the quality of ADR documen-
tation will be crucial to minimize adverse healthcare
events.
This study was limited by its retrospective methodol-
ogy and relatively small sample size. The small sample
size was a result of the timing of the study in respect to the
implementation of the EHR and was also due to the
methodology used for selecting patients. The data col-
lection period was 7–11 months into the EHR rollout,
which did not allow much time for many complete patient
abstractions. Furthermore, the method used to identify
patients with known documented ADRs, using only the
pharmacy system, was not very effective. This contributed
to the small sample size, which was not fully represen-
tative of the entire hospital patient cohort. In the initial
inclusion criteria, not all 1562 patients with complete
medical abstractions in the EHR system were manually
audited. Instead, the study relied on the accuracy of the
pharmacy system to help identify patients. This was done
in order to focus the efforts on evaluating the accuracy of
documentation in patients with known ADRs, excluding
those without ADRs. At the time, it was assumed that the
pharmacy system was the most complete and accurate
system for ADR documentation. However, it appears that
the ADR information in the pharmacy system was not
complete, as 78 (30 %) of the 260 ADRs (see Supple-
mentary Fig. 1) were not actually recorded in the system.
While relying on the pharmacy system to identify patients
helped to narrow the criteria, this strategy excluded many
potential patients with ADRs documented outside the
pharmacy system, which were identified through another
system. Consequently, the restricted inclusion criteria
may have limited the findings, as they failed to provide a
comprehensive evaluation of the process for ADR data
transfer. For a comprehensive review, it is suggested that
a list of patients with documented ADRs in both the HHR
and pharmacy systems should be extracted. This would
have increased the accuracy and eligibility of the patient
cohort. With more resources, a review of the entire patient
cohort with completed medical abstraction would be
optimal.
5 Conclusion
Comprehensive integrated EHRs are expected to provide
complete patient health histories and medication profiles in
an accessible and centralized manner. These systems have
the potential to address current inadequacies in ADR
documentation and to facilitate ADR reporting to health
agencies. Nonetheless, as healthcare institutions transition
to EHRs for the better, discrepancies in ADR documenta-
tion within traditional hospital systems need to be addres-
sed. Processes related to the abstraction and transfer of
patient information into the EHR need to be well defined
and developed. To further improve the quality of ADR
documentation, steps to ensure more complete and con-
tinual ADR verification using an EHR system should be
implemented, and all responsible HCPs should be involved
in the discussion.
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